Market Cap (In USD)
423.96 Thousand
Revenue (In USD)
-
Net Income (In USD)
-1.55 Million
Avg. Volume
1149.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.00505-0.07
- PE
- -
- EPS
- -
- Beta Value
- -0.074
- ISIN
- CA1699161032
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Pierre Laurin B.Sc.Pharm., M.Sc.
- Employee Count
- -
- Website
- https://www.chitogenx.com
- Ipo Date
- 2020-10-06
- Details
- ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
More Stocks
-
RICORicoh Company, Ltd.
RICO
-
MUI
-
MAXINDMax India Limited
MAXIND
-
0HN5Big Lots, Inc.
0HN5
-
CNS
-
LFMDLifeMD, Inc.
LFMD
-
AROGRANITEAro Granite Industries Limited
AROGRANITE
-
DMTRF3-D Matrix, Ltd.
DMTRF